Aranesp is a medicine used to treat anaemia (low red blood cell counts) that is causing symptoms. It is used in two groups of patients: - adults and children with chronic renal failure (long-term, decreasing in the ability of the kidneys to work properly); - adults who are receiving chemotherapy for non‑myeloid cancer (cancer not originating in the bone marrow). Aranesp contains the active substance darbepoetin alfa.
Therapeutic Indication
### Therapeutic indication Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients. Treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Therapeutic Area (MeSH)
ATC Code
B03XA02
ATC Item
darbepoetin alfa
Pharmacotherapeutic Group
Other antianemic preparations
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| darbepoetin alfa | N/A | 达依泊汀α |
EMA Name
Aranesp
Medicine Name
Aranesp
Aliases
N/A